U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06794606) titled 'Multimodal Study for the Diagnosis and Treatment of Drug-resistant Focal Epilepsies' on Dec. 06, 2024.
Brief Summary: Epilepsy is a clinical condition that affects about fifty million people worldwide, with an estimated occurrence of 16-51 new cases per 100,000 people each year (Kwan et al, 2011; Fiest et al, 2017). In 60% of these patients, the origin of seizures is due to a localized (focal) alteration of the brain. In about 25 percent of patients with focal epilepsy, drug treatment is ineffective, a condition defined by the International League Against Epilepsy (ILAE) as drug-resistant epilepsy (Kwan et al, 2010); this condition ...